Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis

Mod Rheumatol. 2023 Dec 23:road112. doi: 10.1093/mr/road112. Online ahead of print.

Authors

Affiliations

¹ Division of Allergy and Rheumatology, Department of Internal Medicine, School of Medicine Iwate Medical University, Japan.
² Institute for Biomedical Sciences Molecular Pathophysiology, Iwate Medical University, Japan.
³ Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

PMID: 38141246
DOI: 10.1093/mr/road112

No abstract available

Keywords: biomarker; disease activity; leucine-rich α2-glycoprotein; rheumatoid arthritis.